GH研究制药 GHRS
$18.61 +$0.17 (+0.92%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $18.61 0.00%
开盘$18.56
昨收$18.44
当日区间$18.13 – $18.78
成交量453.6K
市值$1.28B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$19.45M-32.4% YoY
净利润-$15.15M-63.1% YoY
摊薄每股收益-$0.23-53.3% YoY
自由现金流-$15.04M-66.6% YoY
经营现金流-$15.02M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-18.8%
资产收益率-18.2%
投入资本回报率-19.8%
流动比率28.70
负债/资产比率3.5%
现金及投资$362.65M
总负债$6,000.00
净现金（净负债）$362.64M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $19.45M | $18.75M | $60.68M | $16.70M | $16.54M |
| 销售及管理费用 | $7.06M | $6.37M | $21.65M | $5.25M | $5.92M |
| -管理费用 | $7.06M | $6.37M | $21.65M | $5.25M | $5.92M |
| 研发费用 | $12.40M | $12.38M | $38.77M | $11.39M | $10.57M |
| 资产减值损失 | -$7,000.00 | -$1,000.00 | -$42,000.00 | -$18,000.00 | -$30,000.00 |
| 营业利润 | -$19.45M | -$18.75M | -$60.68M | -$16.70M | -$16.54M |
| 非经营性利息净收入（支出） | $966,000.00 | $582,000.00 | $4.62M | $722,000.00 | $980,000.00 |
| 非经营性利息收入 | $1.05M | $666,000.00 | $5.08M | $812,000.00 | $1.00M |
| 非经营性利息支出 | $6,000.00 | $6,000.00 | $35,000.00 | $8,000.00 | $8,000.00 |
| 其他财务成本合计 | $77,000.00 | $78,000.00 | $428,000.00 | $82,000.00 | $13,000.00 |
| 其他收入（支出） | $3.34M | -$801,000.00 | $7.80M | $1.84M | $1.54M |
| 证券出售收益 | $3.34M | -$801,000.00 | $7.80M | $1.84M | $1.54M |
| 税前利润 | -$15.15M | -$18.97M | -$48.26M | -$14.14M | -$14.02M |
| 税费 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 净利润 | -$15.15M | -$18.97M | -$48.26M | -$14.14M | -$14.02M |
| 持续经营利润 | -$15.15M | -$18.97M | -$48.26M | -$14.14M | -$14.02M |
| 归属母公司净利润 | -$15.15M | -$18.97M | -$48.26M | -$14.14M | -$14.02M |
| 归属普通股股东净利润 | -$15.15M | -$18.97M | -$48.26M | -$14.14M | -$14.02M |
| 基本每股收益 | -$0.23 | -$0.31 | -$0.79 | -$0.23 | -$0.23 |
| 摊薄每股收益 | -$0.23 | -$0.31 | -$0.79 | -$0.23 | -$0.23 |
| 折旧、摊销与折耗 | – | – | $302,000.00 | $78,000.00 | $79,000.00 |
| -折旧与摊销 | – | – | $302,000.00 | $78,000.00 | $79,000.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $372.35M | $275.27M | $288.23M | $288.23M | $302.02M |
| 流动资产合计 | $368.82M | $272.23M | $285.98M | $285.98M | $294.79M |
| 现金及现金等价物与短期投资 | $362.65M | $267.33M | $280.71M | $280.71M | $288.51M |
| -现金及现金等价物 | $345.05M | $242.65M | $246.25M | $246.25M | $249.65M |
| -短期投资 | $17.60M | $24.67M | $34.46M | $34.46M | $38.85M |
| 其他流动资产 | $6.17M | $4.91M | – | – | $6.28M |
| 非流动资产合计 | $3.53M | $3.04M | $2.25M | $2.25M | $7.23M |
| 固定资产净值 | $502,000.00 | $580,000.00 | $620,000.00 | $620,000.00 | $692,000.00 |
| 其他非流动资产 | $3.02M | $2.46M | – | – | – |
| 负债合计 | $12.86M | $11.89M | $8.53M | $8.53M | $10.63M |
| 流动负债合计 | $12.85M | $11.82M | $8.38M | $8.38M | $10.41M |
| 应付款 | $5.93M | $5.21M | $4.27M | $4.27M | $3.84M |
| -应付账款 | $5.93M | $5.21M | $3.77M | $3.77M | $3.84M |
| 短期债务及融资租赁负债 | $354,000.00 | $357,000.00 | $365,000.00 | $365,000.00 | $365,000.00 |
| -一年内到期融资租赁负债 | $354,000.00 | $357,000.00 | $365,000.00 | $365,000.00 | $365,000.00 |
| 其他流动负债 | $6.57M | $6.25M | $407,000.00 | $407,000.00 | $6.21M |
| 非流动负债合计 | $6,000.00 | $75,000.00 | $147,000.00 | $147,000.00 | $217,000.00 |
| 长期债务及融资租赁负债 | $6,000.00 | $75,000.00 | $147,000.00 | $147,000.00 | $217,000.00 |
| -长期融资租赁负债 | $6,000.00 | $75,000.00 | $147,000.00 | $147,000.00 | $217,000.00 |
| 股东权益合计 | $359.49M | $263.38M | $279.70M | $279.70M | $291.40M |
| 股东权益 | $359.49M | $263.38M | $279.70M | $279.70M | $291.40M |
| 股本 | $1.72M | $1.55M | $1.55M | $1.55M | $1.55M |
| -普通股 | $1.72M | $1.55M | $1.55M | $1.55M | $1.55M |
| 资本公积 | $542.67M | $431.13M | $431.06M | $431.06M | $431.06M |
| 留存收益 | -$187.84M | -$173.23M | -$154.43M | -$154.43M | -$140.29M |
| 不影响留存收益的损益 | $2.94M | $3.92M | $1.52M | $1.52M | -$927,000.00 |
| 应收款 | – | – | $1.30M | $1.30M | – |
| -应收税款 | – | – | $137,000.00 | $137,000.00 | – |
| -其他应收款 | – | – | $1.16M | $1.16M | – |
| 预付资产 | – | – | $3.97M | $3.97M | – |
| -固定资产原值 | – | – | $1.68M | $1.68M | – |
| -累计折旧 | – | – | -$1.06M | -$1.06M | – |
| 投资及预付款 | – | – | $0.00 | $0.00 | $5.38M |
| 一年以上应收账款 | – | – | $1.63M | $1.63M | $1.16M |
| -其他应付款 | – | – | $495,000.00 | $495,000.00 | – |
| 一年内应计费用 | – | – | $3.34M | $3.34M | – |
| -可供出售证券 | – | – | – | – | $5.38M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$15.02M | -$10.67M | -$43.55M | -$12.33M | -$13.68M |
| 持续经营经营活动现金流净额 | -$15.02M | -$10.67M | -$43.55M | -$12.33M | -$13.68M |
| 持续经营净利润 | -$15.15M | -$18.97M | -$48.26M | -$14.14M | -$14.02M |
| 持续经营损益 | -$1.73M | $2.33M | -$1.75M | -$140,000.00 | $247,000.00 |
| 折旧、折耗与摊销 | $91,000.00 | $91,000.00 | $335,000.00 | $88,000.00 | $89,000.00 |
| 其他非现金项目 | -$2.57M | -$2.11M | -$10.67M | -$2.42M | -$2.76M |
| 营运资金变动 | -$845,000.00 | $2.96M | -$3.09M | -$1.56M | -$2.90M |
| 投资活动现金流净额 | $6.34M | $8.64M | $46.17M | $8.84M | $9.78M |
| 持续经营投资活动现金流净额 | $6.34M | $8.64M | $46.17M | $8.84M | $9.78M |
| 固定资产购置及出售净额 | -$17,000.00 | -$63,000.00 | -$121,000.00 | -$19,000.00 | -$39,000.00 |
| 投资购置及出售净额 | $6.36M | $8.70M | $46.29M | $8.86M | $9.82M |
| 筹资活动现金流 | $111.87M | $2,000.00 | $139.65M | -$68,000.00 | -$66,000.00 |
| 持续经营筹资活动现金流净额 | $111.87M | $2,000.00 | $139.65M | -$68,000.00 | -$66,000.00 |
| 债务发行及偿还净额 | -$71,000.00 | -$70,000.00 | -$197,000.00 | -$68,000.00 | -$66,000.00 |
| 普通股发行净额 | $117.97M | $72,000.00 | $150.00M | $0.00 | $0.00 |
| 期末现金余额 | $345.05M | $242.65M | $246.25M | $246.25M | $249.65M |
| 现金净变动 | $103.19M | -$2.03M | $142.27M | -$3.56M | -$3.96M |
| 期初现金余额 | $242.65M | $246.25M | $100.79M | $249.65M | $253.87M |
| 汇率变动影响 | -$789,000.00 | -$1.57M | $3.19M | $155,000.00 | -$255,000.00 |
| 自由现金流 | -$15.04M | -$10.73M | -$43.67M | -$12.35M | -$13.72M |
| 其他筹资费用净额 | – | – | -$10.15M | $0.00 | $0.00 |
暂无评论——快来第一个聊聊 GHRS。
登录后参与讨论。